Daily Recap: BF/B, ORLA/EQX, ITRK, TWO/UWMC, TBI/HQI, VFS, ASRT, BWTX

Research evidence excerpt

Daily Recap: BF/B, ORLA/EQX, ITRK, TWO/UWMC, TBI/HQI, VFS, ASRT, BWTX

ack given the ~20% voting

lockup only covers a minority of ORLA's register. The strategic logic is sound: EQX needed to

scale beyond its Calibre merger to achieve senior producer status and indexation eligibility, while

ORLA's Musselwhite mine provides the third Canadian anchor asset that transforms the combined

portfolio. The $475M/$250M break fee structure is notably large (2.6%/2.7% of respective market

caps), providing strong deal protection.The stock should trade well near-term as the market prices

in the re-rating from mid-tier to senior producer status, with the primary risk being gold price

reversion and Mexican regulatory complexity around Camino Rojo/Los Filos.

Intertek Group plc (ITRK - £56.60)

Board Signals It Would Be Minded to Recommend Fourth and Final Take-Private Proposal;

Pauses Strategic Review, Grants Due Diligence Access. On May 13, 2026, ITRK announced that

after rejecting three prior EQT proposals (£51.50, £54.00, and £58.00/share), its Board "would

be minded" to recommend EQT's fourth and final £60/share all-cash offer (~£9.2B equity value,

~£10.6B EV including debt, ~$12.5B), subject to satisfactory completion of confirmatory due

diligence and agreement of definitive documentation. Including ITRK's FY'25 final dividend of

107.7p/share, total shareholder value is £61.08/share. The cash consideration represents a +59%

premium to ITRK's closing price on April 9 (the day before EQT's initial approach). ITRK has paused its

previously announced strategic review (disclosed April 14, 2026), which contemplated separating

into two businesses (Intertek Energy & Infrastructure and Intertek Testing & Assurance) via de-

merger or sale, targeted for completion by mid-2027.